Hello, everyone. Another busy day is about to unfold here on the Pharmalot corporate campus, as we prepare for a round of meetings and deadlines. To cope, we are our brewing our mandatory cup of stimulation - we continue to favor Wild Mountain Blueberry this week. Meanwhile, here are some items to help you get started. Hope your day goes well and stay in touch...
Par Pharma Pays $153M To Settle Pricing Lawsuits (Reuters)
Sanofi-Aventis Profit Falls Due To Generics (Bloomberg News)
More US Women Are Using The Morning After Pill (Reuters)
Roche Wins FDA Approval For HPV Diagnostics Test (Bloomberg News)
AstraZeneca Profits Get A Lift From Tax Breaks (Pharma Times)
Merck Hepatitis C Drug Wins FDA Panel Backing (Boston Globe)
Australia Delays Subsidies For Some Medicines (Australian Broadcasting Corp News)
Lilly Says Court Blocks Generic Cymbalta (Associated Press)
Spain Reports Drug Registrations Are Soaring (Pharma Times)